Jeroen van de Pol

183 6 General discussion [50] McDonald R, Cheraghi-Sohi S, Sanders C et al. Professional status in a changing world: The case of medicines use reviews in English community pharmacy. Soc Sci Med. 2010;71(3):451–8. [51] SFK. Tariefinkomsten blijven ver achter bij loonkosten zorg. Pharmaceutisch Weekblad. 2019. [52] Ernst &Young. Impacts of funding, policy and economic environment on independent pharmacy in England. 2020. URL: https://www.npa.co.uk/wp-content/uploads/2020/09/EY-NPA-Impacts- of-current-funding-policy-and-economic-environment-on-pharmacy-in-England-FINAL.pdf [53] Leal-Rodríguez AL, Eldridge S, Roldán JL et al. Organizational unlearning, innovation outcomes, and performance: The moderating effect of firm size. J Bus Res. 2015;68(4):803–9. [54] Mertens, BJ, Kwint, HF, Bouvy, ML et al. Eindcontrole kan efficiënter. Pharmaceutisch Weekblad. 2017. [55] Roberts AS, Benrimoj SI (Charlie), Chen TF et al. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Pract. 20061;14(3):163–70. [56] Ferreri SP, Greco AJ, Michaels NM et al. Implementation of a pharmacogenomics service in a community pharmacy. J Am Pharm Assoc (2003). 2014;54(2):172–80. [57] Calo WA, Shah PD, Gilkey MB et al. Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states. Hum Vaccin Immunother. 2019;15(7–8):1831–8. [58] Hossain LN, Fernandez-Llimos F, Luckett T et al. Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners. BMJ Open. 2017;7(9):e015471. [59] Shoemaker SJ, Curran GM, Swan H et al. Application of the Consolidated Framework for Implementation Research to community pharmacy: A framework for implementation research on pharmacy services. Res Social Adm Pharm. 2017;13(5):905–13. [60] Mossialos E, Courtin E, Naci H et al. From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119(5):628–39. [61] Roberts AS, Benrimoj SIC, Chen TF et al. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm. 2005;1(4):546–64. [62] Lynas K. Reimbursement model for pharmacy services takes effect in Alberta. Can Pharm J (Ott). 2012;145(5):209. [63] Judson TJ, Volpp KG, Detsky AS. Harnessing the Right Combination of Extrinsic and Intrinsic Motivation to Change Physician Behavior. JAMA. 2015;314(21):2233–4. [64] Miller MJ, Ortmeier BG. Factors influencing the delivery of pharmacy services. Am Pharm. 1995;NS35(1):39–45. [65] Stichting Farmaceutische Kengetallen. Data en feiten 2020: Het jaar 2019 in cijfers. ISBN/EAN 978-90-830805-0-5. [66] Velzel E, Heida JP, Cozijnsen M. Versterking van de zorgfunctie van openbaar apothekers. 28 maart 2018. URL: https://www.knmp.nl/downloads/rapport-versterking-van-de-zorgfunctie- van-openbaar-apothekers.pdf/view [67] Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract J R Coll Gen Pract. 2003;53(493):600–6.